Increased sales were driven by growth from the company’s disruptive technology products, which include minimally invasive surgical and lateral platform products. Globus Medical also reported quarter net income of $16.5 million, down slightly from $16.9 million in the same quarter last year.
More Articles on Orthopedic Devices:
X-spine Announces FDA Approval for 2 Spine Systems
